| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014220 Vaccine Against Hpv16 And Hpv18 And At Least Another Hpv Type Selected From Hpv 31, 45 Or 52 |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014196 Compositions and methods for modulating vascular development |
| 01/17/2008 | US20080014192 Methods For The Diagnosis And Treatment of Fungal Infections Caused By Microorganisms Producing Glucosylceramide |
| 01/17/2008 | US20080014188 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 01/17/2008 | US20080014182 Populations of Expanded and Re-Differentiated Adult Islet Beta Cells Capable of Producing Insulin and Methods of Generating Same |
| 01/17/2008 | US20080014181 Cell separation apparatus and methods of use |
| 01/17/2008 | US20080014180 Hemangio-colony forming cells |
| 01/17/2008 | US20080014179 Tissue transplantation compositions and methods |
| 01/17/2008 | US20080014173 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 01/17/2008 | US20080014154 Novel Ethylene Copolymers, Compositions Containing Said Copolymers and Treatment Method |
| 01/17/2008 | US20080014148 Perturbed membrane-binding compounds and methods of using the same |
| 01/17/2008 | US20080014144 Methods of Treatment with Drug Loaded Polymeric Materials |
| 01/17/2008 | US20080014143 Methods and compositions for targeting gC1qR/p32 |
| 01/17/2008 | CA2658097A1 Pentadienamide derivatives |
| 01/17/2008 | CA2657117A1 Crystals of benzoxadiazole derivative |
| 01/16/2008 | EP1878743A2 Urotensin-II agonists and antagonists |
| 01/16/2008 | EP1878734A1 Novel lactam compound |
| 01/16/2008 | EP1878732A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1878436A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 01/16/2008 | EP1878431A1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues |
| 01/16/2008 | EP1878429A1 Trenadermal absorption preparation |
| 01/16/2008 | EP1878428A1 1-(substituted phenyl)-5- methyl- 2 - (1h) pyridone in the manufacture of medicaments for treating fibrosis in organs or tissues |
| 01/16/2008 | EP1877076A1 Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration |
| 01/16/2008 | EP1877043A1 Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1451154B1 Inhibitors of cytosolic phospholipase a2 |
| 01/16/2008 | EP1429754B1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1351979B1 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1317432B1 Piperidine derivatives for use as 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 01/16/2008 | EP1315793B1 Methods for culturing human lung mast cells and uses thereof |
| 01/16/2008 | EP1279039B1 Diagnostic assay involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/16/2008 | EP1278532B1 Plant extract of the olea europaea species as no-synthase inhibitor and uses |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1261694B1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | EP1200118B1 A pharmaceutical formulation comprising megalatran and its prodrug |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | EP0938486B1 Substituted pyrrolopyrimidines and processes for their preparation |
| 01/16/2008 | CN101106987A Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same |
| 01/16/2008 | CN101104632A Antisense oligonucleotide using apoptosis gene Caspase-4 as drone and use thereof |
| 01/16/2008 | CN101104059A Pedicure five-element health-preserving toxin-expelling tea |
| 01/16/2008 | CN101104002A Application of fly maggot protein powder in preparing anti-fatigue and immunity-improving product |
| 01/16/2008 | CN101103984A Pharmaceutical compositions |
| 01/16/2008 | CN100361987C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 01/15/2008 | US7319160 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 01/15/2008 | US7319148 Comprising reactive hydrazide function used as initial synthons for preparing compounds capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319107 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride |
| 01/15/2008 | US7319096 Antiarrhythmia agents; liver disorders; skin disorders |
| 01/15/2008 | US7319093 Antidiabetic 2-substituted-5′-O-(1-Boranotriphosphate) adenosine derivatives |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 01/15/2008 | CA2400567C Tamper-resistant oral opioid agonist formulations |
| 01/15/2008 | CA2332559C High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 01/15/2008 | CA2169191C Neural regeneration using human bone morphogenetic proteins |
| 01/15/2008 | CA2145527C Tissue protective and regenerative compositions |
| 01/10/2008 | WO2008005451A2 Optical apparatus and methods for chemical analysis |
| 01/10/2008 | WO2008004673A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 01/10/2008 | WO2008004653A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | WO2008004610A1 Method of treating genetic disease caused by nonsense mutation |
| 01/10/2008 | WO2008004406A1 Agent for modulating mast cell degranulation |
| 01/10/2008 | WO2008004341A1 α-SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES |
| 01/10/2008 | WO2008004340A1 Senescence inhibitor |
| 01/10/2008 | WO2008003978A2 Dioxo-alkanes and dioxo-alkenes |
| 01/10/2008 | WO2008003864A1 Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins |
| 01/10/2008 | WO2008003667A2 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 01/10/2008 | WO2008003299A1 Basic acetophenones as inhibitors of no-synthases |
| 01/10/2008 | WO2008003245A1 The use of rosmarinic acid in the manufacture of medicaments for treating or preventing hepatic and renal diseases |
| 01/10/2008 | WO2008003141A1 Therapeutic compounds |
| 01/10/2008 | WO2006108488A8 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009552 Markers of pre-term labor |
| 01/10/2008 | US20080009551 Methods and Compositions for Identifying Modulators of G Protein-Coupled Receptors |
| 01/10/2008 | US20080009541 N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxoprolinamide; modulate P2X7 receptor function and are capable of antagonizing the effects of ATP at the P2X7 receptor; treatment of disorders mediated by the P2X7 receptor, for example pain, inflammation and neurodegeneration |
| 01/10/2008 | US20080009540 Amorphous Atorvastatin Calcium |
| 01/10/2008 | US20080009534 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009523 New Pyridine Analogues IV |
| 01/10/2008 | US20080009522 Biphenylcarboxamides useful as lipid lowering agents |
| 01/10/2008 | US20080009520 Benzimidazolidinone derivatives as muscarinic agents |
| 01/10/2008 | US20080009500 Alpha-helix mimetics and methods relating to the treatment of fibrotic disorders |
| 01/10/2008 | US20080009495 Compound Containing Basic Group and Use Thereof |
| 01/10/2008 | US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines |
| 01/10/2008 | US20080009476 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
| 01/10/2008 | US20080009470 Acremonic Acid Derivatives |
| 01/10/2008 | US20080009458 medical diagnosis of cancer comprising detecting constitutive photomorphogenic 1(COP1) molecule in a sample of the cancer, wherein gene overexpression of the (COP1) molecule relative to a control is indicative of cancer |
| 01/10/2008 | US20080009456 modified oligonucleotide for gene therapy; as antitumor agent, anticarcinogenic agent; Inhibiting synthesis and function; arresting cellular proliferation |